These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32961061)

  • 1. Performance verification of anti-SARS-CoV-2-specific antibody detection by using four chemiluminescence immunoassay systems.
    Wan Y; Li Z; Wang K; Li T; Liao P
    Ann Clin Biochem; 2020 Nov; 57(6):429-434. PubMed ID: 32961061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays.
    Qian C; Zhou M; Cheng F; Lin X; Gong Y; Xie X; Li P; Li Z; Zhang P; Liu Z; Hu F; Wang Y; Li Q; Zhu Y; Duan G; Xing Y; Song H; Xu W; Liu BF; Xia F
    Clin Chem Lab Med; 2020 Aug; 58(9):1601-1607. PubMed ID: 32609640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of the serum IgM and IgG to SARS-CoV-2 in coronavirus disease-2019.
    Wu LX; Wang H; Gou D; Fu G; Wang J; Guo BQ
    J Clin Lab Anal; 2021 Jan; 35(1):e23649. PubMed ID: 33184940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).
    Charpentier C; Ichou H; Damond F; Bouvet E; Chaix ML; Ferré V; Delaugerre C; Mahjoub N; Larrouy L; Le Hingrat Q; Visseaux B; Mackiewicz V; Descamps D; Fidouh-Houhou N
    J Clin Virol; 2020 Nov; 132():104618. PubMed ID: 32919222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis.
    Li Z; Yi Y; Luo X; Xiong N; Liu Y; Li S; Sun R; Wang Y; Hu B; Chen W; Zhang Y; Wang J; Huang B; Lin Y; Yang J; Cai W; Wang X; Cheng J; Chen Z; Sun K; Pan W; Zhan Z; Chen L; Ye F
    J Med Virol; 2020 Sep; 92(9):1518-1524. PubMed ID: 32104917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A point-of-care selenium nanoparticle-based test for the combined detection of anti-SARS-CoV-2 IgM and IgG in human serum and blood.
    Wang Z; Zheng Z; Hu H; Zhou Q; Liu W; Li X; Liu Z; Wang Y; Ma Y
    Lab Chip; 2020 Nov; 20(22):4255-4261. PubMed ID: 33064114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary Analysis of B- and T-Cell Responses to SARS-CoV-2.
    Zhang LX; Miao SY; Qin ZH; Wu JP; Chen HY; Sun HB; Xie Y; Du YQ; Shen J
    Mol Diagn Ther; 2020 Oct; 24(5):601-609. PubMed ID: 32710269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three automatic chemiluminescent immunoassays for monitoring dynamic profile of SARS-CoV-2 IgG and IgM.
    Dou X; Wang E; Hu J; Zong Z; Jiang R; Wang M; Kan L; Zhang X
    J Clin Lab Anal; 2021 Jan; 35(1):e23681. PubMed ID: 33340166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies.
    Mairesse A; Favresse J; Eucher C; Elsen M; Tré-Hardy M; Haventith C; Gruson D; Dogné JM; Douxfils J; Göbbels P
    Clin Biochem; 2020 Dec; 86():23-27. PubMed ID: 32858061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation.
    Risch M; Weber M; Thiel S; Grossmann K; Wohlwend N; Lung T; Hillmann D; Ritzler M; Ferrara F; Bigler S; Egli K; Bodmer T; Imperiali M; Salimi Y; Fleisch F; Cusini A; Renz H; Kohler P; Vernazza P; Kahlert CR; Paprotny M; Risch L
    Biomed Res Int; 2020; 2020():9878453. PubMed ID: 33224987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of heat inactivation of blood samples on the efficacy of three detection methods of SARS-CoV-2 antibodies].
    Xue X; Zhu C; Huang S; Pan L; Xu J; Li W
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Mar; 40(3):316-320. PubMed ID: 32376571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience.
    Infantino M; Grossi V; Lari B; Bambi R; Perri A; Manneschi M; Terenzi G; Liotti I; Ciotta G; Taddei C; Benucci M; Casprini P; Veneziani F; Fabbri S; Pompetti A; Manfredi M
    J Med Virol; 2020 Sep; 92(9):1671-1675. PubMed ID: 32330291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays.
    Kweon OJ; Lim YK; Kim HR; Kim MC; Choi SH; Chung JW; Lee MK
    PLoS One; 2020; 15(10):e0240395. PubMed ID: 33091042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMI.
    Selingerova I; Valik D; Gescheidtova L; Sramek V; Cermakova Z; Zdrazilova-Dubska L
    J Med Virol; 2021 Mar; 93(3):1805-1809. PubMed ID: 33079389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of lateral flow tests in SARS-CoV-2 infection monitorization.
    Candel FJ; Viñuela-Prieto JM; González Del Castillo J; Barreiro García P; Fragiel Saavedra M; Hernández Píriz A; Jiménez Virumbrales D; Canora Lebrato J; García de Casasola G; Gil Prieto R; San-Román Montero J; Ortega Anselmi J; Barba Martín R; Prados Roa F; Marco Martínez J; Zapatero Gaviria A
    Rev Esp Quimioter; 2020 Aug; 33(4):258-266. PubMed ID: 32492991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of the main haematological indexes and RNA detection for the diagnosis of SARS-CoV-2 infection.
    Xiang J; Chen Z; Zhou J; Tian D; Ran X; Zhang Z; Shi S; Xiao D; Zhou Y
    BMC Infect Dis; 2020 Oct; 20(1):779. PubMed ID: 33081702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic and meta-analysis review on the diagnostic accuracy of antibodies in the serological diagnosis of COVID-19.
    Vengesai A; Midzi H; Kasambala M; Mutandadzi H; Mduluza-Jokonya TL; Rusakaniko S; Mutapi F; Naicker T; Mduluza T
    Syst Rev; 2021 May; 10(1):155. PubMed ID: 34039423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical performance of lateral flow immunoassay for SARS-CoV-2 exposure screening on venous and capillary blood samples.
    Black MA; Shen G; Feng X; Garcia Beltran WF; Feng Y; Vasudevaraja V; Allison D; Lin LH; Gindin T; Astudillo M; Yang D; Murali M; Iafrate AJ; Jour G; Cotzia P; Snuderl M
    J Immunol Methods; 2021 Feb; 489():112909. PubMed ID: 33166549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of combined detection of SARS-CoV-2-specific antibody and nucleic acid.
    Meng QB; Peng JJ; Wei X; Yang JY; Li PC; Qu ZW; Xiong YF; Wu GJ; Hu ZM; Yu JC; Su W
    World J Clin Cases; 2020 Oct; 8(19):4360-4369. PubMed ID: 33083395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.